Cargando…
Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin
BACKGROUND: Rifampin is a first line antituberculosis drug active against bacilli in logarithmic and stationary phase, which interferes with RNA synthesis by binding to bacterial RNA polymerase. Tubercle bacilli achieve resistance to rifampin by accumulation of mutations in a short-81 bp region of t...
Autores principales: | Zaczek, Anna, Brzostek, Anna, Augustynowicz-Kopec, Ewa, Zwolska, Zofia, Dziadek, Jaroslaw |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652454/ https://www.ncbi.nlm.nih.gov/pubmed/19146699 http://dx.doi.org/10.1186/1471-2180-9-10 |
Ejemplares similares
-
rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis
por: Li, Ma-chao, et al.
Publicado: (2021) -
rpoB Mutations are Associated with Variable Levels of Rifampin and Rifabutin Resistance in Mycobacterium tuberculosis
por: Li, Ma-Chao, et al.
Publicado: (2022) -
Few amino acid positions in rpoB are associated with most of the rifampin resistance in Mycobacterium tuberculosis
por: Cummings, Michael P, et al.
Publicado: (2004) -
Investigation of the rpoB Mutations Causing Rifampin Resistance by Rapid Screening in Mycobacterium Tuberculosis in North-East of Iran
por: Tajbakhsh, Amir, et al.
Publicado: (2018) -
rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates from rural areas of Zhejiang, China
por: Zeng, Mei-Chun, et al.
Publicado: (2021)